The campaign film evocatively captures the agonising pain caused by shingles and its debilitating impact on the people living with it. It gives an important message that it is possible to protect ageing adults against this pain through vaccination. Shingles is caused by the same virus that causes chickenpox.

GSK wanted to sound the alarm about shingles, so they built a campaign around one of the most notable aspects of the disease: chicken pox. Everyone who has had chicken pox (99% of those over the age of 50) carries the varicella-zoster virus inside them.

GSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content to the person receiving it. Richard Staines heard about this new strategy at the Veeva 2019 Commercial and Medical Summit, Europe.

Summary. GlaxoSmithKline spent under $100 million on advertising in digital, print, and national TV in the last year. They invest in premium ad units and advertised on over 250 different Media Properties in the last year across multiple Media formats.

SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) will replace ZOSTAVAX® (zoster vaccine live) for the whole shingles programme. SHINGRIX® will require a two-dose schedule for all cohorts. The dosing interval will differ for severely immunosuppressed and immunocompetent patients.

The term "shingles" comes from the Latin word "cingulum," which means belt or girdle; this is because the rash usually appears in a band or belt-like pattern. Shingles can affect people of all ages. It is particularly common in adults over age 50 years.

A marketing strategy is a long-term plan for achieving a company's goals by understanding the needs of customers and creating a distinct and sustainable competitive advantage. It encompasses everything from determining who your customers are to deciding what channels you use to reach those customers.

We apply our strengths and take action in the areas that can most positively impact patients, society and our people over the long-term. This includes pricing and access, sustainability, global health and health security, diversity, equity and inclusion, product governance and operating standards.

Our vaccines portfolio is the broadest in the industry, helping protect people from meningitis, shingles, flu, polio, measles and many more. Today, one and a half million doses of our vaccines are administered daily, and around 40% of the world's children receive a GSK jab each year.

CDC recommends Shingrix as the preferred vaccine, over Zostavax, to prevent shingles and the complications from the disease. Shingrix provides stronger protection against shingles compared to Zostavax.

Indication: SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older. SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).

Shingles may cause skin sensitivity ranging from mild itching to severe pain along with burning, tingling, or numbness. A rash with fluid-filled blisters nearly always appears on just one side of the body or face. The rash usually lasts for 7 to 10 days.